| Phase 4 |
| NCT06494072 |
Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP |
Community Acquired Pneumonia in Children |
Recruiting |
| NCT03527537 |
Gestational Diabetes and Pharmacotherapy (GAP) |
Gestational Diabetes |
Active, Not Recruiting |
| NCT05557370 |
Immunogenicity of HPV Vaccine in Transplant Recipients. |
Chronic Kidney Diseases |
Active, Not Recruiting |
| Phase 2 |
| NCT03322995 |
Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial |
Pancreatic Cancer |
Recruiting |
| NCT04240054 |
Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in… |
Multiple Myeloma |
Recruiting |
| NCT06517641 |
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal… |
Severe Aplastic Anemia |
Recruiting |
| NCT04683315 |
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression… |
Pancreatic Cancer |
Recruiting |
| NCT05045950 |
Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed… |
Brain Metastases |
Recruiting |
| NCT05622318 |
De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD)… |
Graft-versus-host Disease |
Active, Not Recruiting |
| NCT04335656 |
Reducing Innate Inflammation in New Onset Type 1 Diabetes |
Type 1 Diabetes |
Active, Not Recruiting |
| NCT05690984 |
Elimination of Minimal Residual Disease After Transplant |
Multiple Myeloma |
Active, Not Recruiting |
| NCT04835129 |
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory… |
Multiple Myeloma |
Active, Not Recruiting |
| NCT06683534 |
Palmitic Acid and Human Microvascular Function |
Microvascular Dysfunction |
Not Yet Recruiting |
| NCT06723561 |
Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord… |
Central Neuropathic Pain |
Active, Not Recruiting |
| NCT04383262 |
Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction |
Laryngopharyngeal Reflux |
Not Yet Recruiting |
| NCT06594939 |
Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly… |
Diffuse Large B Cell Lymphoma (DLBCL) |
Not Yet Recruiting |
| NCT07009899 |
BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM) |
Multiple Myeloma |
Not Yet Recruiting |
| NCT07226713 |
Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That… |
Prostate Cancer |
Not Yet Recruiting |
| NCT07572929 |
A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable… |
Myeloid Disorders |
Not Yet Recruiting |
| NCT01972919 |
MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic… |
Unresectable Pancreatic Cancer |
Active, Not Recruiting |
| NCT07643428 |
Cancer Lipidome Adaptation and Resculping Through Omega-3 PUFAs in Breast Tumors |
Breast Cancer |
Not Yet Recruiting |
| Phase 1/2 |
| NCT04186520 |
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies |
Non Hodgkin Lymphoma (NHL) |
Recruiting |
| NCT05853601 |
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage |
Acute Kidney Injury |
Recruiting |
| NCT05674825 |
Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for… |
Cancer |
Recruiting |
| Phase 1 |
| NCT07093554 |
Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by… |
Relapse Multiple Myeloma |
Recruiting |